$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy

American journal of kidney diseases : the official journal of the National Kidney Foundation, v.36 no.6, 2000년, pp.1193 - 1200  

Kramer, L. ,  Gendo, A. ,  Madl, C. ,  Ferrara, I. ,  Funk, G. ,  Schenk, P. ,  Sunder-Plassmann, G. ,  Horl, W.H.

Abstract AI-Helper 아이콘AI-Helper

Extracorporeal detoxification has been proposed to treat patients with hepatic encephalopathy (HE) not responding to standard therapy. To investigate the biocompatibility of a cuprophane charcoal-based detoxification device, a prospective, randomized, controlled study was performed. Of 41 consecutiv...

주제어

참고문헌 (40)

  1. Eur J Clin Invest Ferenci 22 573 1992 10.1111/j.1365-2362.1992.tb01508.x Current concepts in the pathophysiology of hepatic encephalopathy 

  2. Ferenci 443 1999 Hepatic encephalopathy: Treatment 

  3. Neurochem Pathol Butterworth 6 1 1987 10.1007/BF02833598 Ammonia: A key factor in the pathogenesis of hepatic encephalopathy 

  4. Gastroenterology Basile 108 818 1995 10.1016/0016-5085(95)90456-5 The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy 

  5. Semin Liver Dis Mullen 16 255 1996 10.1055/s-2007-1007238 Natural benzodiazepines and hepatic encephalopathy 

  6. Semin Liver Dis Hughes 16 435 1996 10.1055/s-2007-1007256 Use of bioartificial and artificial liver support devices 

  7. Gastroenterology O’Grady 94 1186 1988 10.1016/0016-5085(88)90011-X Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure 

  8. Eur J Clin Invest Weston 7 401 1977 10.1111/j.1365-2362.1977.tb01626.x Biocompatibility of coated and uncoated charcoal during haemoperfusion in healthy dogs 

  9. Int J Artif Organs Ash 15 151 1992 Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT) 

  10. ASAIO J Ash 38 382 1992 Neurologic improvement of patients with hepatic failure and coma during sorbent suspension dialysis 

  11. Int J Artif Organs Hughes 17 657 1994 10.1177/039139889401701207 Evaluation of the BioLogic-DT sorbent-suspension dialyzer in patients with fulminant hepatic failure 

  12. Int J Artif Organs Ellis 22 27 1999 10.1177/039139889902200107 Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the Biologic-DT 

  13. Semin Liver Dis Rolando 16 389 1996 10.1055/s-2007-1007252 Bacterial and fungal infection in acute liver failure 

  14. Liver Transpl Surg Hughes 1 200 1995 10.1002/lt.500010312 Evaluation of extracorporeal bioartificial liver devices 

  15. Am J Kidney Dis Hakim 32 suppl 4 S71 1998 10.1016/S0272-6386(98)70165-9 Influence of the dialysis membrane on outcome of ESRD patients 

  16. Kidney Int Hörl 28 791 1985 10.1038/ki.1985.199 Plasma levels of granulocyte elastase during hemodialysis: Effects of different dialyzer membranes 

  17. Artif Organs Gawaz 23 29 1999 10.1046/j.1525-1594.1999.06289.x Platelet-leukocyte aggregates during hemodialysis: Effect of membrane type 

  18. N Engl J Med Arnaout 312 457 1985 10.1056/NEJM198502213120801 Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis 

  19. J Am Soc Nephrol Böhler 7 234 1996 10.1681/ASN.V72234 Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: Dissociation of complement activation and neutropenia from neutrophil degranulation 

  20. Am J Kidney Dis Canivet 21 41 1994 10.1016/S0272-6386(12)80810-9 Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis 

  21. Am J Kidney Dis Girndt 35 95 2000 10.1016/S0272-6386(00)70307-6 Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction 

  22. N Engl J Med Hakim 331 1338 1994 10.1056/NEJM199411173312003 Effect of the dialysis membrane in the treatment of patients with acute renal failure 

  23. J Am Soc Nephrol Himmelfarb 9 257 1998 10.1681/ASN.V92257 A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis 

  24. Lancet Schiffl 344 570 1994 10.1016/S0140-6736(94)91964-X Biocompatible membranes in acute renal failure: Prospective case-controlled study 

  25. Lancet Jörres 354 1337 1999 10.1016/S0140-6736(99)01213-1 Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: A prospective randomised multicentre trial 

  26. Haemostasis Paramo 25 305 1995 Increased concentrations of tumor necrosis factor and interleukin-6 contribute to the hemostatic abnormalities in advanced liver disease 

  27. Am J Gastroenterol Genesca 94 169 1999 10.1111/j.1572-0241.1999.00790.x Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis 

  28. N Engl J Med Levi 341 586 1999 10.1056/NEJM199908193410807 Disseminated intravascular coagulation 

  29. Int J Artif Organs Ellis 22 27 1999 10.1177/039139889902200107 Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT 

  30. J Hepatol Bakker 15 330 1992 10.1016/0168-8278(92)90064-V Disseminated intravascular coagulation in liver cirrhosis 

  31. Scand J Gastroenterol Prytz 11 857 1976 10.1080/00365521.1976.12097199 Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis 

  32. Gastroenterology Violi 109 531 1995 10.1016/0016-5085(95)90342-9 Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis 

  33. Am Surg Cohen 56 665 1990 The inactivation of antithrombin III by serum elastase in patients with surgical infections 

  34. Cancer Gabazza 72 2134 1993 10.1002/1097-0142(19931001)72:7<2134::AID-CNCR2820720712>3.0.CO;2-8 Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer 

  35. Am J Gastroenterol Ben-Ari 94 2977 1999 10.1111/j.1572-0241.1999.01446.x Disseminated intravascular coagulation in liver cirrhosis: Fact or fiction? 

  36. Circulation Pernerstorfer 100 2485 1999 10.1161/01.CIR.100.25.2485 Heparin blunts endotoxin-induced coagulation activation 

  37. Blood Pernerstorfer 95 1729 2000 10.1182/blood.V95.5.1729.005k16_1729_1734 Lepirudin blunts endotoxin-induced coagulation activation 

  38. Wien Klin Wochenschr Apsner 109 123 1997 Impairment of citrate metabolism in acute hepatic failure 

  39. Hepatology Kramer 28 410A 1998 A controlled study of the BioLogic-DT system in chronic hepatic encephalopathy 

  40. Clin Nephrol Hörl 25 304 1986 Different complement and granulocyte activation in patients dialyzed with PMMA dialysers 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로